Mannkind (MNKD) Return on Capital Employed (2011 - 2026)
Mannkind (MNKD) reported Return on Capital Employed of 2.34% for Q1 2026, down 2498.0% year-over-year from 0.1% in Q1 2025, and down 71.49% quarter-over-quarter from 8.21% in Q4 2025.
Mannkind (MNKD) Return on Capital Employed (2011 - 2026) Analysis & Trends
Mannkind (MNKD) has 16 years of Return on Capital Employed data on file, last reported at 2.34% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 2.34%, down 2498.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 2.34% (down 2498.0% YoY), and the FY2025 annual result was 9.19%, down 1139.0% from the prior year.
- Return on Capital Employed fell to 2.34% in Q1 2026 per MNKD's latest filing, from 8.21% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 27.32% in Q1 2025 and troughed at 32.7% in Q3 2022.
- A 5-year average of 0.95% and a median of 2.96% in 2023 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2023 and 2026: Return on Capital Employed jumped 3116 bps in 2023, then tumbled 2498 bps in 2026.
- A 5-year view of Return on Capital Employed shows it stood at 28.21% in 2022, then soared by 110 bps to 2.96% in 2023, then jumped by 607 bps to 20.91% in 2024, then slumped by 61 bps to 8.21% in 2025, then plunged by 71 bps to 2.34% in 2026.
- Business Quant data shows MNKD's Return on Capital Employed at 2.34% in Q1 2026, 8.21% in Q4 2025, and 21.21% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 450.31% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 51.73% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -107.40% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -50.43% |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | 2.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.34% |
| Dec 31, 2025 | 8.21% |
| Sep 30, 2025 | 21.21% |
| Jun 30, 2025 | 22.35% |
| Mar 31, 2025 | 27.32% |
| Dec 31, 2024 | 20.91% |
| Sep 30, 2024 | 14.13% |
| Jun 30, 2024 | 12.11% |
| Mar 31, 2024 | 8.30% |
| Dec 31, 2023 | 2.96% |
| Sep 30, 2023 | -5.43% |
| Jun 30, 2023 | -12.78% |
| Mar 31, 2023 | -22.74% |
| Dec 31, 2022 | -28.21% |
| Sep 30, 2022 | -32.70% |
| Jun 30, 2022 | -30.43% |
| Mar 31, 2022 | -23.77% |
| Dec 31, 2021 | -20.33% |
| Sep 30, 2021 | -23.94% |
| Jun 30, 2021 | -21.87% |